List of Studies ( Metabolite:PE 21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004203 | AN006989 | RPR2 NE nonNE comparison | Tumor cells | Mouse | Cancer | Stanford University | LC-MS |
| ST002576 | AN005612 | Role of environmental toxicants in obesity-related cardiovascular disease: Plasma untargeted LC-HRMS analysis (part 1 of 3) | Blood | Human | Heart disease | Boston University | LC-MS |
| ST000624 | AN000956 | Human trabecular meshowrk phospholipid profiles of control and glaucomatous eyes | Eye tissue | Human | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST000616 | AN000945 | Human Aqueous Humor Phospholipids in Control and Glaucomatous eyes | Eye tissue | Human | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST000579 | AN000890 | DBA2J Phosphatidylethanolamine Analysis | Eye tissue | Mouse | Eye disease | University of Miami | LC-MS |
| ST000551 | AN000841 | Investigating large scale metabolomics in mice tissue lacking insulin receptors and IGF-1 receptors | Muscle | Mouse | Diabetes | Mayo Clinic | LC-MS |
| ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000422 | AN000668 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000664 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000665 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000079 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
